Sage Therapeutics

📍 Cambridge, United States🗓 Founded 2010👥 234 employees💰 Last funded Mar 2023
Biotechnology Research🌐 sagerx.com
Website LinkedIn
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more than just a destination. We’re concerned with the journey, and we care deeply about everyone contributing to and benefiting from our own company journey. This means helping people discover the right path for them and carefully guiding colleagues along the way. Read our Community Guidelines: http://bit.ly/2tFyAoj
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2010
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sage Therapeutics?
Sage Therapeutics has 1 investors on record on gritt.io.
When did Sage Therapeutics last raise funding?
The most recent investment in Sage Therapeutics recorded on gritt.io was in March 2023.
When was Sage Therapeutics founded?
Sage Therapeutics was founded in 2010.
What industry is Sage Therapeutics in?
Sage Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Sage Therapeutics based?
Sage Therapeutics is headquartered in Cambridge, United States.